Study identifies new E3 ligase for targeted protein degradation
A new study in Structure, a Cell Press journal demonstrates that DCAF2 can be harnessed as a novel E3 ligase for targeted protein degradation (TPD). The authors say DCAF2 presents an exciting opportunity to deliver tumour-targeted protein degraders given its frequent overexpression in various types… Read More